Chemoinformaics analysis of [1-(CARBAMOYLAMINO)-2-METHYLPROPYL]UREA
| Molecular Weight | 174.204 | nRot | 3 |
| Heavy Atom Molecular Weight | 160.092 | nRig | 18 |
| Exact Molecular Weight | 174.112 | nRing | 0 |
| Solubility: LogS | -4.712 | nHRing | 0 |
| Solubility: LogP | 3.276 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.3591 |
| nHD | 4 | BPOL | 15.7809 |
| QED | 0.655 |
| Synth | 2.22 |
| Natural Product Likeliness | 0.768 |
| NR-PPAR-gamma | 0.182 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 1 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.66 |
| MDCK | 0.0000549 |
| BBB | 0.096 |
| PPB | 0.713683 |
| VDSS | 0.955 |
| FU | 0.242135 |
| CYP1A2-inh | 0.618 |
| CYP1A2-sub | 0.981 |
| CYP2c19-inh | 0.737 |
| CYP2c19-sub | 0.867 |
| CYP2c9-inh | 0.682 |
| CYP2c9-sub | 0.925 |
| CYP2d6-inh | 0.08 |
| CYP2d6-sub | 0.941 |
| CYP3a4-inh | 0.813 |
| CYP3a4-sub | 0.571 |
| CL | 6.749 |
| T12 | 0.59 |
| hERG | 0.045 |
| Ames | 0.333 |
| ROA | 0.132 |
| SkinSen | 0.071 |
| Carcinogencity | 0.032 |
| EI | 0.072 |
| Respiratory | 0.108 |
| NR-Aromatase | 0.868 |
| Antiviral | No |
| Prediction | 0.851024 |